Literature DB >> 15547430

Vestibular evoked myogenic potentials versus vestibular test battery in patients with Meniere's disease.

Steven D Rauch1, M Beatriz Silveira, Guangwei Zhou, Sharon G Kujawa, Conrad Wall, John J Guinan, Barbara S Herrmann.   

Abstract

OBJECTIVE: The present study was undertaken to assess the sensitivity of vestibular evoked myogenic potentials testing to side-of-disease in Meniere's disease patients and to test the hypothesis that information supplied by vestibular evoked myogenic potentials is complementary to that provided by a conventional vestibular test battery. STUDY
DESIGN: Prospective cohort study.
SETTING: Large specialty hospital, department of otolaryngology.
SUBJECTS: Twenty consenting adults (9 men and 11 women) with unilateral Meniere's disease by American Academy of Otolaryngology-Head and Neck Surgery diagnostic criteria.
INTERVENTIONS: All subjects underwent bilateral vestibular evoked myogenic potentials testing using ipsilateral broadband click and short-toneburst stimuli at 250, 500, and 1,000 Hz. All subjects also underwent electronystagmography and sinusoidal vertical axis rotation testing. MAIN OUTCOME MEASURES: Accuracy of side-of-disease assignment by vestibular evoked myogenic potentials, caloric asymmetry, and multivariate analysis.
RESULTS: Side-of-disease assignment was most accurate using caloric asymmetry with a 5% interaural difference criterion, achieving 85% correct assignment. The next best method was vestibular evoked myogenic potentials using 250-Hz toneburst stimuli, achieving 80% correct assignment. The least accurate method was caloric asymmetry using a traditional 30% interaural difference limen, achieving 55% correct assignment. Comparison of 5% interaural difference criterion and vestibular evoked myogenic potentials using 250-Hz toneburst stimuli showed discordant results, but in no case did both 5% interaural difference criterion and vestibular evoked myogenic potentials using 250-Hz toneburst stimuli make an incorrect assignment.
CONCLUSION: Vestibular evoked myogenic potentials threshold was shown to be highly sensitive to side-of-disease in unilateral Meniere's disease. We observed instances of discordance in side-of-disease assignment by caloric asymmetry and vestibular evoked myogenic potential methods but no case in which both methods were incorrect. This supports the hypothesis that vestibular evoked myogenic potentials supplies information complementary to that provided by other components of the vestibular test battery.

Entities:  

Mesh:

Year:  2004        PMID: 15547430     DOI: 10.1097/00129492-200411000-00020

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  5 in total

1.  Cervical Vestibular Evoked Myogenic Potentials in Menière's Disease: A Comparison of Response Metrics.

Authors:  Kimberley S Noij; Barbara S Herrmann; John J Guinan; Steven D Rauch
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

2.  Glycerol pure tone audiometry and glycerol vestibular evoked myogenic potential: representing specific status of endolymphatic hydrops in the inner ear.

Authors:  Jae Ho Ban; Jong Kyu Lee; Sung Min Jin; Kyung Chul Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-28       Impact factor: 2.503

3.  Power reflectance as a screening tool for the diagnosis of superior semicircular canal dehiscence.

Authors:  Gabrielle R Merchant; Christof Röösli; Marlien E F Niesten; Mohamad A Hamade; Daniel J Lee; Melissa L McKinnon; Cagatay H Ulku; John J Rosowski; Saumil N Merchant; Hideko Heidi Nakajima
Journal:  Otol Neurotol       Date:  2015-01       Impact factor: 2.311

4.  Abnormal Cervical Vestibular-Evoked Myogenic Potentials Predict Evolution of Isolated Recurrent Vertigo into Meniere's Disease.

Authors:  Sun-Uk Lee; Hyo-Jung Kim; Jeong-Yoon Choi; Ja-Won Koo; Ji-Soo Kim
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

Review 5.  Vestibular evoked myogenic potential: recording methods in humans and guinea pigs.

Authors:  Aline Cabral de Oliveira; Ricardo David; José Fernando Colafêmina
Journal:  Braz J Otorhinolaryngol       Date:  2008 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.